A chance encounter with an inspiring ALS patient, prompted Alon Ben-Noon to set up NeuroSense Therapeutics, a startup ...

Athira Pharma is refocusing efforts on ATH-1105 after its Alzheimer’s drug, fosgonimeton, failed to meet endpoints in the ...

Launched in 2020 to more quickly bring to market an effective medicine for amyotrophic lateral sclerosis, the HEALEY Platform ...

A blood test has been shown to accurately identify patients with amyotrophic lateral sclerosis at early stages, which could ...

People living with ALS, family members, friends, caregivers and anyone affected by the disease will come together for the ...

People with rare genetic variants linked to degenerative brain disorders like Parkinson's disease are at increased risk of ...

Clene will present to the FDA’s Office on New Drugs, Office of Neuroscience, and DN1 review team, along with key opinion leaders in the field of ALS. The discussion will address questions on ALS ...

A simple blood test has been shown to be 98% accurate at distinguishing between patients with ALS and those without the ...

ALS, MS, post-traumatic brain injury? This biotech company has a target choice to make for an upcoming clinical trial — and ...

Verge Genomics and Ferrer have partnered to co-develop VRG50635, a promising AI-discovered drug for ALS treatment. Ferrer will develop and commercialize the drug in select global markets, while Verge ...

PSC-derived cells and micro-physiological systems provide significant advancements in enhancing neuronal disease models, ...